Physician profile
Aimee Levy
NPI 1902946486
$1,387.79
in general payments reported to CMS, 2019-2025
12 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.81 · 2021: $99.75 · 2022: $483 · 2023: $325 · 2024: $176 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $494.00 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $346.74 | 2021-2023 | Echelon; Endopath, Enseal, Echelon Endopath |
| Medtronic, INC. | $185.95 | 2022-2023 | Ligasure |
| Karl Storz Endoscopy-America | $88.40 | 2022 | |
| Intuitive Surgical, INC. | $84.02 | 2024 | |
| Tela Bio, INC. | $34.70 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $33.47 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $31.34 | 2019-2024 | Exparel, Iovera, Zilretta |
| Polynovo North America LLC | $27.20 | 2024 | Novosorb Btm |
| Mallinckrodt Enterprises LLC | $26.29 | 2019 | |
| La Jolla Pharmaceutical Company | $20.56 | 2021 | |
| Innocoll Pharmaceuticals Limited | $15.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.